Publications

5674 Results

Evaluation of immunoscore and immune biomarkers in stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial (NCCTG N0147; Alliance)

Authors
F Sinicrope;Q Shi;F Hermitte;E Heying;A Benson;S Gill;R Goldberg;MS Kahlenberg;S Nair;A Shields;S Sargent;J Galon;S Alberts
Journal / Conference
Annals of Oncology Jun 1;28(suppl_3) LBA
Year
2017
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/N0147

End points and statistical considerations in immuno-oncology trials: impact on multiple myeloma.

Authors
A Hoering;BGM Durie;H Wang;J Crowley
Journal / Conference
Future Oncology Jun;13(13):1181-1193
Year
2017
Research Committee(s)
Leukemia and Myeloma
PMID
PMID28395525
PMC
PMC5705823
Study Number(s)
S0106, SWOG-9321

A phase III randomized comparison of medroxyprogesterone acetate versus observation for the prevention of endometrial pathology in postmenopausal patients with breast cancer treated with adjuvant tamoxifen: SWOG S9630

Authors
R Potkul;J Unger;R Livingston;S Wilczynski;C Salomon;B Smith;L Wong;DL Campbell;D Einspahr;G Anderson;G Goodman;P Brown;F Meyskens;K Albain
Journal / Conference
NPJ Breast Cancer Aug 10;2:16024
Year
2016
Research Committee(s)
Breast
PMID
PMID28721383
PMC
PMC5515330
Study Number(s)
S9630

Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial

Authors
P Goodman;C Tangen;A Darke;K Arnold;M Yee;J Hartline;K Anderson;A Caban-Holt;W Christen;P Cassano;MP Lance;EA Klein;J Crowley;L Minasian;F Meyskens
Journal / Conference
Trials 17:400
Year
2016
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID27519183
PMC
PMC4983010
Study Number(s)
S0000

PAM50 gene signatures are prognostic for breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy in C9741 (Alliance)

Authors
MC Liu;BN Pitcher;ER Mardis;SR Davies;JE Snider;TL Vickery;JP Reed;K DeSchryver;B Singh;PN Friedman;WJ Gradishar;EA Perez;S Martino;M Citron;L Norton;EP Winer;CA Hudis;LA Carey;TO Nielsen;CM Perou;MJ Ellis;WT Barry
Journal / Conference
NPJ Breast Cancer 2016;2. pii: 15023. doi: 10.1038/npjbcancer.2015.23.
Year
2016
Research Committee(s)
Breast
PMID
PMID28691057
PMC
PMC5501351
Study Number(s)
C9741

Prediction of CR following a second course of "7+3" in patients with newly diagnosed acute myeloid leukemia not in CR after a first course

Authors
M Othus;S Mukherjee;MA Sekeres;JE Godwin;SH Petersdorf;F Appelbaum;H Erba;E Estey
Journal / Conference
Leukemia Aug;30(8):1779-1780; 2016 Feb 29 [Epub ahead of print]
Year
2016
Research Committee(s)
Leukemia
PMID
PMID27055872
PMC
PMC4980556
Study Number(s)
S0106, SWOG-8600, SWOG-9031, SWOG-9333

Disease control rate at 8 weeks predicts subsequent survival in platinum-treated extensive stage small cell lung cancer (ES-SCLC): a patient level analysis of SWOG trials

Authors
P Lara;J Moon;M Redman;T Semrad;K Kelly;JW Allen;B Gitlitz;PC Mack;D Gandara
Journal / Conference
Clinical Lung Cancer, Mar;17(2):113-118
Year
2016
Research Committee(s)
Lung
PMID
PMID26498504
PMC
PMC4789142
Study Number(s)
S0327, S0435, S0802

Social support and its implications in elderly, early-stage breast cancer patients in CALGB 49907 (Alliance A171301)

Authors
A Jatoi;H Muss;J Allred;H Cohen;K Ballman;J Gralow;JO Hopkins;A Gajra;J Lafky;A Hurria
Journal / Conference
Psychooncology Apr;25(4):441-6; 2015 May 20. doi: 10.1002/pon.3850
Year
2016
Research Committee(s)
Breast
PMID
PMID25994447
PMC
PMC4864498

Prostate cancer susceptibility in men of African ancestry at 8q24

Authors
Y Han;K Rand;D Hazlett;S Ingles;RA Kittles;S Strom;B Rybicki;B Nemesure;W Isaacs;J Stanford;W Zheng;F Schumacher;S Berndt;Z Wang;J Xu;N Rohland;D Reich;A Tandon;B Pasaniuc;A Allen;D Quinque;S Mallick;D Notani;M Rosenfeld;R Jayani;S Kolb;SM Gapstur;V Stevens;C Pettaway;E Yeboah;Y Tettey;R Biritwum;A Adjei;E Tay;A Truelove;S Niwa;A Chokkalingam;E John;A Murphy;L Signorello;J Carpten;C Leske;S-Y Wu;A Hennis;C Neslund-Dudas;A Hsing;L Chu;P Goodman;EA Klein;SL Zheng;J Witte;G Casey;S Kaggwa;A Lubwama;L Pooler;S Sheng;G Coetzee;M Cook;S Chanock;D Stram;S Watya;W Blot;D Conti;B Henderson;CA Haiman
Journal / Conference
Journal of the National Cancer Institute Jan 27;108(7). pii: djv431. doi: 10.1093/jnci/djv431. Print 2016 Jul.
Year
2016
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID26823525
PMC
PMC4849351
Study Number(s)
S0000

Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis

Authors
D Winchester;B Gurel;C Till;P Goodman;C Tangen;R Santella;T Paris-Johnson;RJ Leach;IM Thompson;J Xu;S Zheng;MS Lucia;SM Lippman;H Parnes;W Isaacs;CD Drake;A De Marzo;E Platz
Journal / Conference
Prostate, May;76(6):565-574
Year
2016
Research Committee(s)
Cancer Control
PMID
PMID26771888
PMC
PMC4841624
Study Number(s)
SWOG-9217